Affinium Pharma Bags $15M Round
Affinium Pharmaceuticals, the Austin, Texas-based drug company, has closed a $15 million round, its Series B, from existing investors SV Life Sciences, Genesis Capital Partners and Forward Ventures. The Ontario Emerging Technologies Fund is also participating in the round.
30 August 2011•2 mins read
